Esomeprazole
- Molecular formula
- C17H19F2N3O3S
- CAS Number
- 119141-88-7
- IUPAC Name
- 6-(difluoromethoxy)-2-[(3,4-dimethoxy-2-pyridyl)methylsulfinyl]-1H-benzimidazole
- Molecular Weight
- 345.42g/mol
- Melting Point
- (Celsius)
- Boiling Point
- (Celsius)
- Density
- 1.4000g/cm3
- Synonyms
- pantoprazole
Identification
Interesting Facts about 6-(Difluoromethoxy)-2-[(3,4-dimethoxy-2-pyridyl)methylsulfinyl]-1H-benzimidazole
This compound, known scientifically as 6-(difluoromethoxy)-2-[(3,4-dimethoxy-2-pyridyl)methylsulfinyl]-1H-benzimidazole, brings together a unique blend of functional groups and molecular characteristics that make it particularly interesting for research and applications in medicinal chemistry.
- Complex structure: The architecture of this compound is characterized by its benzimidazole core, which is known for its presence in various biologically active molecules.
- Pharmacological potential: Compounds with substituted benzimidazole structures often demonstrate a range of pharmacological activities, including anticancer, anthelmintic, and anti-inflammatory properties.
- Fluorine substitution: The introduction of difluoromethoxy features in organic compounds can significantly alter their reactivity and biological activity, potentially increasing their potency or altering their metabolic pathways.
- Sulfinyl linkage: The presence of the methylsulfinyl group hints at its ability to participate in redox reactions, which could be crucial for certain therapeutic effects.
In the realm of medicinal chemistry, structure-activity relationships (SAR) often dictate the efficacy of drug candidates. The unique features of this compound provide an excellent platform for further study, with potential applications in drug design. As researchers continue to explore derivatives and analogs, understanding the role of each functional group will be key in predicting biological behavior and enhancing therapeutic efficacy. As one chemist put it, "The devil is in the details," and in this case, those details may lead to significant advancements in pharmacotherapy.